Marta Tagliabue
Marta Tagliabue
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
1,✉,#,
Fausto Maffini
Fausto Maffini
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,#,
Caterina Fumagalli
Caterina Fumagalli
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,#,
Sara Gandini
Sara Gandini
3Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy
3,
Daniela Lepanto
Daniela Lepanto
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,
Federica Corso
Federica Corso
3Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy
3,
Salvatore Cacciola
Salvatore Cacciola
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
1,
Alberto Ranghiero
Alberto Ranghiero
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,
Alessandra Rappa
Alessandra Rappa
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,
Davide Vacirca
Davide Vacirca
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,
Maria Cossu Rocca
Maria Cossu Rocca
4Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
4,
Daniela Alterio
Daniela Alterio
5Division of Radiotherapy, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
5,
Elena Guerini Rocco
Elena Guerini Rocco
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
6Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy
2,6,
Augusto Cattaneo
Augusto Cattaneo
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
1,
Francesco Chu
Francesco Chu
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
1,
Stefano Zorzi
Stefano Zorzi
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
1,
Giuseppe Curigliano
Giuseppe Curigliano
6Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy
7Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
6,7,
Susanna Chiocca
Susanna Chiocca
3Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy
3,
Massimo Barberis
Massimo Barberis
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2,
Giuseppe Viale
Giuseppe Viale
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
6Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy
2,6,
Mohssen Ansarin
Mohssen Ansarin
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
1
1Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy
2Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
3Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy
4Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
5Division of Radiotherapy, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
6Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy
7Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.